Cancer-Help.org provides news and information on cancer,   gathering articles on hundreds of cancer-related topics   from more than 1,500 sources across the web.

Here and Now: Inspiring Stories of Cancer Survivors -- by Elena Dorfman, Heidi Schultz Adams Kathy's Hats: A Story of Hope Kathy's Hats: A Story of Hope by Trudy Krisher My Mommy's Cancer by Cindy Klein Cohen Beating Cancer With Nutrition by Patrick Quillin A Cancer Battle Plan: Six Strategies for Beating Cancer, from a Recovered "Hopeless Case" by Anne E. Frahm, David J. Frahm How to Fight Cancer & Win by William L. Fischer What to Eat if You Have Cancer by Daniella Chace The Cure for All Cancers: Including over 100 Case Histories of Persons Cured by Hulda Regehr Clark Just Get Me Through This: The Practical Guide to Breast Cancer by Deborah A. Cohen

gemtuzumab ozogamicin A type of monoclonal antibody used in cancer detection or therapy. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. (National Cancer Institute) Genta Incorporated Announces Fourth Quarter and Year End 2004 ... Feb 17, 2005 Acute myeloid leukemia (AML): At the December 2004 ASH meeting, results from a Phase 2 trial of Genasense plus Mylotarg(R) (gemtuzumab ozogamicin) showed that ... Yahoo News (press release) Resources from the National Cancer Institute on gemtuzumab ozogamicin: Cancer.gov  Phase III Randomized Study of Daunorubicin and Cytarabine With or Without Gemtuzumab Ozogamicin Followed By Autologous Hematopoietic Stem Cell Transplantation ... Cancer.gov  Phase II Pilot Study of Gemtuzumab Ozogamicin in Children With Newly Diagnosed Acute Myeloid Leukemia Undergoing Intensive Remission Induction and ... Cancer.gov  Phase I Study of Gemtuzumab Ozogamicin in Patients With Relapsed Acute Myeloid Leukemia After Autologous or Allogeneic Hematopoietic Stem Cell Transplantation. ... Cancer.gov  Phase I Study of Gemtuzumab Ozogamicin in Combination With Conventional Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia or ... Cancer.gov  Phase III Randomized Study of Standard Induction Chemotherapy With or Without Gemtuzumab Ozogamicin in Elderly Patients With Previously Untreated Acute Myeloid ... Cancer.gov  Phase II Study of Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Patients With Previously Untreated High-Risk Myelodysplastic Syndromes (MDS) or Acute ... Cancer.gov  Phase II Study of Gemtuzumab Ozogamicin and Cytarabine in Patients With Relapsed Acute Myeloid Leukemia. Date Last Modified: 2003-04-01. ... Cancer.gov  Phase II Study of Gemtuzumab Ozogamicin (CMA-676) and High-Dose Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia. ... Outstanding University Cancer Center  File Format: PDF/Adobe Acrobat - View as HTML ... mos Tot To Date SuperPha rm Leukemia SP-990 Gonzalez, R 2 7/3/01 II Treat Genasense (Bcl-2 Antisense) Combined with Mylotarg (gemtuzumab ozogamicin) in Elderly ... List of Approved Oncology Drugs with Approved Indications  File Format: PDF/Adobe Acrobat - View as HTML ... Page 3 of 4 gemtuzumab- ozogamicin Mylotarg Chemo Treatment of CD33 positive acute myeloid leukemia in patients in first relapse who are 60 years of age or ...

Web cancer-help.org Home | Cancers | Treatments | Regional! | Vitamins | Vaccines | Health | Hospitals | About Lottery News Futures Trading News Copyright Cancer-Help.org 2003-2004. All Rights Reserved.